Clinical Trials Browser

Multiple Myeloma × Leukapheresis × 30 days × Clear all

NCT07340853 2026-03-10

CRISPR Delivered Anti-BCMA Car-T Therapy for Relapsed or Refractory Multiple Myeloma

Phase 1 Recruiting

Multiple Myeloma